Abbott Labs is set to report its Q1 2018 earnings on April 18, and we expect the company to post solid numbers, primarily led by its Diagnostics business, reflecting the benefits of the Alere acquisition. We also expect the company's Generic Pharmaceuticals segment to post steady growth...
Abbott Labs is set to report its Q1 2018 earnings on April 18, and we expect the company to post solid numbers, primarily led by its Diagnostics business, reflecting the benefits of the Alere acquisition. We also expect the company's Generic Pharmaceuticals segment to post steady growth...
Share this Article
Recommended